Form 4 for ARDX ARDELYX, INC.
Accepted 2024-05-23 00:00:00 ET · period of report 2024-05-21 · accession 0001628280-24-024955 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-05-23 | 2024-05-21 | ARDX | Williams Laura A | Chief Medical Off | S - Sale | $7.81 | -4,794 | 367.2K | -1% | -$37.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-21 | S | D | 4,794 | $7.81 | 367,152 | D | — | — | (F2) Reflects the adjusted total which includes the purchase of 1,757 shares under the Ardelyx Employee Stock Purchase Plan in February 2024. |